<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02725801</url>
  </required_header>
  <id_info>
    <org_study_id>16-0064</org_study_id>
    <nct_id>NCT02725801</nct_id>
  </id_info>
  <brief_title>Comparison of One-port and Two-port Tissue Expanders for Breast Reconstruction</brief_title>
  <official_title>Randomized Clinical Trial Comparing 1-Port and 2-Port Tissue Expanders for Breast Reconstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lesley Wong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Kentucky</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Appropriate patients undergoing going immediate breast reconstruction with tissue expanders&#xD;
      following mastectomy will be randomized to receive one-port or two-ports tissue expanders.&#xD;
      Their clinical course, complications, and outcome will be analyzed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of this study is to compare a traditional single port expander with a two-port&#xD;
      expander for equivalency when used for breast reconstruction following mastectomy.&#xD;
      Complication rates that will be tracked include seroma, mastectomy skin flap necrosis,&#xD;
      infection, wound dehiscence, need for explantation of the expander. Management of seromas&#xD;
      will be compared between the two groups. The investigators hypothesize that the AlloX2&#xD;
      expander will be as effective in achieving the final outcome of completion of the second&#xD;
      stage of reconstruction with equal or improved complication rates.&#xD;
&#xD;
      Study Design A prospective 1:1 randomized, single center, open label study will compare the&#xD;
      traditional 1- port tissue expander with the AlloX2 2-port expander placed during immediate&#xD;
      tissue expander breast reconstruction. Due to the nature of the surgery, the study cannot be&#xD;
      blinded. Patients will be followed until completion of expansion and exchange for the&#xD;
      permanent implant which typically takes 2 to 3 months. Risks factors that have been&#xD;
      previously identified to be associated with increased postoperative complications include&#xD;
      smoking, obesity, breast size, diabetes, radiation therapy, and expander fill volume will be&#xD;
      identified. The final outcome is completion of expansion and exchange to permanent implant.&#xD;
&#xD;
      Standard operative procedure and postoperative care will be done. Both groups will have the&#xD;
      same two external drains placed which is standard operative procedure. Complications will be&#xD;
      noted at each postoperative clinic visit and entered into a database. Complication rates will&#xD;
      be compared between the two groups and associations with risk factors will be analyzed. There&#xD;
      will be no cross-over into the other group in case of reconstructive failure. Treatment&#xD;
      failures will be treated in the same fashion in the two groups.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Actual">April 1, 2020</completion_date>
  <primary_completion_date type="Actual">July 19, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Successful Replacement of Tissue Expander With Permanent Implant</measure>
    <time_frame>3 months</time_frame>
    <description>The number of patients that are able to undergo replacement of the tissue expander between the two arms will be compared</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Required Additional Intervention</measure>
    <time_frame>3 months</time_frame>
    <description>Number of participants requiring additional intervention following tissue expander placement will be compared between the two arms of the study</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>one-port</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intervention is placement of one-port tissue expander at time of reconstruction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>two-port</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intervention is placement of two-port tissue expander at time of reconstruction</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Allergen one-port tissue expander placement</intervention_name>
    <description>patients will be randomized to receive a one port or two port tissue expander for breast reconstruction</description>
    <arm_group_label>one-port</arm_group_label>
    <other_name>Allergen one-port tissue expander</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AlloX2 two-port tissue expander placement</intervention_name>
    <description>patients will be randomized to receive a one port or two port tissue expander for breast reconstruction</description>
    <arm_group_label>two-port</arm_group_label>
    <other_name>AlloX2 two-port tissue expander</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient agrees to immediate tissue expander breast reconstruction&#xD;
&#xD;
          -  a suitable patient for tissue expander reconstruction&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  not a surgical candidate for immediate breast reconstruction&#xD;
&#xD;
          -  age less than 18&#xD;
&#xD;
          -  patient declines tissue expander reconstruction&#xD;
&#xD;
          -  patient anticipated to need radiation therapy postoperatively&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lesley Wong, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Kentucky</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>February 27, 2016</study_first_submitted>
  <study_first_submitted_qc>March 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2016</study_first_posted>
  <results_first_submitted>July 29, 2020</results_first_submitted>
  <results_first_submitted_qc>August 19, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 4, 2020</results_first_posted>
  <last_update_submitted>August 19, 2020</last_update_submitted>
  <last_update_submitted_qc>August 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Kentucky</investigator_affiliation>
    <investigator_full_name>Lesley Wong</investigator_full_name>
    <investigator_title>Associate Professor of Plastic Surgery</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 17, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/01/NCT02725801/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 17, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/01/NCT02725801/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>One-port</title>
          <description>intervention is placement of one-port tissue expander at time of reconstruction&#xD;
Allergen one-port tissue expander placement: patients will be randomized to receive a one port or two port tissue expander for breast reconstruction</description>
        </group>
        <group group_id="P2">
          <title>Two-port</title>
          <description>intervention is placement of two-port tissue expander at time of reconstruction&#xD;
AlloX2 two-port tissue expander placement: patients will be randomized to receive a one port or two port tissue expander for breast reconstruction</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>One-port</title>
          <description>intervention is placement of one-port tissue expander at time of reconstruction&#xD;
Allergen one-port tissue expander placement: patients will be randomized to receive a one port or two port tissue expander for breast reconstruction</description>
        </group>
        <group group_id="B2">
          <title>Two-port</title>
          <description>intervention is placement of two-port tissue expander at time of reconstruction&#xD;
AlloX2 two-port tissue expander placement: patients will be randomized to receive a one port or two port tissue expander for breast reconstruction</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="8"/>
            <count group_id="B2" value="12"/>
            <count group_id="B3" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="8"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="8"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46.75" spread="12.28"/>
                    <measurement group_id="B2" value="51.08" spread="13.83"/>
                    <measurement group_id="B3" value="48.92" spread="3.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="8"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="8"/>
                    <count group_id="B2" value="12"/>
                    <count group_id="B3" value="20"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Successful Replacement of Tissue Expander With Permanent Implant</title>
        <description>The number of patients that are able to undergo replacement of the tissue expander between the two arms will be compared</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>One-port</title>
            <description>intervention is placement of one-port tissue expander at time of reconstruction&#xD;
Allergen one-port tissue expander placement: patients will be randomized to receive a one port or two port tissue expander for breast reconstruction</description>
          </group>
          <group group_id="O2">
            <title>Two-port</title>
            <description>intervention is placement of two-port tissue expander at time of reconstruction&#xD;
AlloX2 two-port tissue expander placement: patients will be randomized to receive a one port or two port tissue expander for breast reconstruction</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Successful Replacement of Tissue Expander With Permanent Implant</title>
          <description>The number of patients that are able to undergo replacement of the tissue expander between the two arms will be compared</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Required Additional Intervention</title>
        <description>Number of participants requiring additional intervention following tissue expander placement will be compared between the two arms of the study</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>One-port</title>
            <description>intervention is placement of one-port tissue expander at time of reconstruction&#xD;
Allergen one-port tissue expander placement: patients will be randomized to receive a one port or two port tissue expander for breast reconstruction</description>
          </group>
          <group group_id="O2">
            <title>Two-port</title>
            <description>intervention is placement of two-port tissue expander at time of reconstruction&#xD;
AlloX2 two-port tissue expander placement: patients will be randomized to receive a one port or two port tissue expander for breast reconstruction</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Required Additional Intervention</title>
          <description>Number of participants requiring additional intervention following tissue expander placement will be compared between the two arms of the study</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 months</time_frame>
      <desc>All-cause mortality was not monitored/assessed.</desc>
      <group_list>
        <group group_id="E1">
          <title>One-port</title>
          <description>intervention is placement of one-port tissue expander at time of reconstruction&#xD;
Allergen one-port tissue expander placement: patients will be randomized to receive a one port or two port tissue expander for breast reconstruction</description>
        </group>
        <group group_id="E2">
          <title>Two-port</title>
          <description>intervention is placement of two-port tissue expander at time of reconstruction&#xD;
AlloX2 two-port tissue expander placement: patients will be randomized to receive a one port or two port tissue expander for breast reconstruction</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>re-operation</sub_title>
                <description>Reoperation for infection or seroma</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Lesley Wong</name_or_title>
      <organization>University of Kentucky Division of Plastic Surgery</organization>
      <phone>859-323-7505</phone>
      <email>lesley.wong@uky.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

